Annual Accounts Payable
$22.06 M
+$15.80 M+252.58%
December 31, 2023
Summary
- As of February 7, 2025, AMLX annual accounts payable is $22.06 million, with the most recent change of +$15.80 million (+252.58%) on December 31, 2023.
- During the last 3 years, AMLX annual accounts payable has risen by +$18.45 million (+510.60%).
- AMLX annual accounts payable is now at all-time high.
Performance
AMLX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.49 M
-$3.47 M-69.99%
September 30, 2024
Summary
- As of February 7, 2025, AMLX quarterly accounts payable is $1.49 million, with the most recent change of -$3.47 million (-69.99%) on September 30, 2024.
- Over the past year, AMLX quarterly accounts payable has dropped by -$4.88 million (-76.66%).
- AMLX quarterly accounts payable is now -93.98% below its all-time high of $24.70 million, reached on June 30, 2023.
Performance
AMLX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMLX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +252.6% | -76.7% |
| 3 y3 years | +510.6% | -76.7% |
| 5 y5 years | +905.1% | -76.7% |
AMLX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +404.6% | -94.0% | at low |
| 5 y | 5-year | at high | +905.1% | -94.0% | at low |
| alltime | all time | at high | +905.1% | -94.0% | at low |
Amylyx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.49 M(-70.0%) |
| Jun 2024 | - | $4.96 M(-76.9%) |
| Mar 2024 | - | $21.45 M(-2.8%) |
| Dec 2023 | $22.06 M(+252.6%) | $22.06 M(+246.3%) |
| Sep 2023 | - | $6.37 M(-74.2%) |
| Jun 2023 | - | $24.70 M(+129.3%) |
| Mar 2023 | - | $10.77 M(+72.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $6.26 M(+43.1%) | $6.26 M(-11.3%) |
| Sep 2022 | - | $7.05 M(-13.1%) |
| Jun 2022 | - | $8.12 M(-19.2%) |
| Mar 2022 | - | $10.04 M(+129.8%) |
| Dec 2021 | $4.37 M(+21.0%) | $4.37 M(+44.5%) |
| Sep 2021 | - | $3.03 M(-16.2%) |
| Dec 2020 | $3.61 M(+64.6%) | $3.61 M |
| Dec 2019 | $2.19 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual accounts payable year-on-year change?
- What is Amylyx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly accounts payable year-on-year change?
What is Amylyx Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMLX is $22.06 M
What is the all time high annual accounts payable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual accounts payable is $22.06 M
What is Amylyx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMLX annual accounts payable has changed by +$15.80 M (+252.58%)
What is Amylyx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMLX is $1.49 M
What is the all time high quarterly accounts payable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly accounts payable is $24.70 M
What is Amylyx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMLX quarterly accounts payable has changed by -$4.88 M (-76.66%)